The Pharmaceutical Group of the European Union (PGEU), an EPHA member, has recently adopted, during its General Assembly, the European Community Pharmacy Blueprint
With a view to making better use of the competences of European pharmacists, the PGEU set out its vision on the European Community Pharmacy Blueprint. PGEU tried to compile in one document the European governments’ goals in terms of optimising the use of medicines, achieving better value from pharmacotherapy of patients, and reducing the overall cost of health care.
The document’s main recommendations are:
To optimise health outcomes to individual patients and add value to health systems across Europe:
To improve medicine safety and access to medicines; boost treatment outcomes of individual patients
To contribute to better efficiency and quality of health systems.
To successfully cope with challenges like changes to demographics, changes to health risk factors, issues around the health workforce, moves to patient-centred care and economic pressures.
For PGEU, the community of pharmacies plays an important role in healthcare systems. Due to the changing of the organisation and structure of healthcare, these professionals need to be ready to provide patients with the best and most cost-effective care possible.
The PGEU’s blueprint raises the following fundamental questions: . How can we do more to improve access to medicines?
. How can we do more for our patients?
. How can we further contribute to public health?
. How can we further contribute to efficiency of health systems?
PGEU’s vision reads as follows: “in order to embrace current and future challenges, we want to create a future where services offered at European community pharmacies, by highly qualified and independent healthcare professionals - community pharmacists - further support individual patients, public health and the healthcare system.”
Key facts and figures
EPHA related articles: